Haemonetics Corp. buy Mizuho
Start price
17.12.25
/
50%
€67.50
Target price
17.12.26
€76.62
Performance (%)
-24.44%
Price
16.02.26
€48.80
Summary
This prediction is currently active. The prediction for Haemonetics Corp. disappoints with a performance of -24.44%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 0.826% | 0.826% |
| iShares Core DAX® | 0,39 % | 0,15 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % |
| iShares S&P 500 | 1,31 % | -1,16 % |
Comments by Mizuho for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat